Lack of p19INK4d in human testicular germ-cell tumours contrasts with high expression during normal spermatogenesis

被引:47
作者
Bartkova, J
Thullberg, M
Rajpert-De Meyts, E
Skakkebæk, NE
Bartek, J
机构
[1] Danish Canc Soc, Inst Canc Biol, DK-2100 Copenhagen O, Denmark
[2] Univ Copenhagen, Dept Growth & Reprod, Rigshosp, Copenhagen, Denmark
关键词
p19(INK4d); RB pathway; spermatogenesis; carcinoma in situ; testicular germ cell tumours;
D O I
10.1038/sj.onc.1203769
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
p19(INK4d) a member of the INK4 family of cyclin-dependent kinase inhibitors, negatively regulates the proto-oncogenic cyclin D/CDK4(6) complexes whose ability to phosphorylate the retinoblastoma tumour suppressor (RB) promotes G1/S transition. In contrast to the related p16(INK4a) tumour suppressor, expression patterns of 19(INK4d) in human tissues and tumours remain unknown. As the RE pathway is commonly targeted in cancer, and mouse models suggest a role for p19(INK4d) in spermatogenesis, ne examined the abundance and localization of p19(INK4d) in the human testis, both during normal development and at various stages of germ-cell tumour pathogenesis. Our data show that the p19(INK4d) protein is abundant in spermatocytes of normal human adult testes, whereas virtually no p19(INK4d) is detectable in testicular cancer, including the preinvasive carcinoma ill situ stage. Together with the lack of p19(INK4d) in human foetal germ cells, these results support the concept of foetal origin of the testicular germ-cell tumours, and help better understand the emerging role of the RE pathway in spermatogenesis and tumorigenesis in the human testis.
引用
收藏
页码:4146 / 4150
页数:5
相关论文
共 38 条
  • [1] Teratocarcinomas and human embryology: Pluripotent human EC cell lines
    Andrews, PW
    [J]. APMIS, 1998, 106 (01) : 158 - 167
  • [2] BARKOVA J, 2000, INT J CANCER, V85, P370
  • [3] The retinoblastoma protein pathway and the restriction point
    Bartek, J
    Bartkova, J
    Lukas, J
    [J]. CURRENT OPINION IN CELL BIOLOGY, 1996, 8 (06) : 805 - 814
  • [4] The retinoblastoma protein pathway in cell cycle control and cancer
    Bartek, J
    Bartkova, J
    Lukas, J
    [J]. EXPERIMENTAL CELL RESEARCH, 1997, 237 (01) : 1 - 6
  • [5] Cyclin D3: requirement for G1/S transition and high abundance in quiescent tissues suggest a dual role in proliferation and differentiation
    Bartkova, J
    Lukas, J
    Strauss, M
    Bartek, J
    [J]. ONCOGENE, 1998, 17 (08) : 1027 - 1037
  • [6] Bartkova J, 1999, J PATHOL, V187, P573, DOI 10.1002/(SICI)1096-9896(199904)187:5<573::AID-PATH289>3.0.CO
  • [7] 2-H
  • [8] BERNARDS R, 1997, BIOCHIM BIOPHYS ACTA, V1333, P33
  • [9] CHAN FKM, 1995, MOL CELL BIOL, V15, P2682
  • [10] Chaubert P, 1997, AM J PATHOL, V151, P859